The Trump administration has once again made headlines with its latest move to support the controversial company, Monsanto. In a recent development, the administration has filed a brief with the Supreme Court in support of Monsanto’s efforts to shield itself from liability over cancer claims related to its popular weedkiller, Roundup. This decision has sparked a wave of criticism and backlash, especially from the Make America Healthy Again (MAHA) movement, who have been vocal in their opposition to Monsanto and its products.
For those unfamiliar with the issue, Roundup is a widely used herbicide that has been on the market for decades. However, in recent years, it has come under scrutiny for its main ingredient, glyphosate, which has been linked to causing cancer. This has led to numerous lawsuits against Monsanto, with many claiming that the company knew about the potential risks of glyphosate but failed to warn consumers.
The Trump administration’s decision to back Monsanto in this legal battle has raised eyebrows, especially since the MAHA movement has been a strong supporter of the administration’s efforts to improve the health and well-being of Americans. Many are questioning the administration’s motives and whether they are putting corporate interests above the health of the people.
In its brief to the Supreme Court, the administration argued that allowing these lawsuits to proceed would create a “patchwork” of different regulations and standards across the country, which would ultimately harm businesses and the economy. They also stated that the Environmental Protection Agency (EPA) has already determined that glyphosate is not a carcinogen and that the lawsuits against Monsanto are based on “junk science.”
This move by the Trump administration has not gone unnoticed by the MAHA movement, who have been vocal in their opposition to glyphosate and its potential health risks. They have accused the administration of betraying their promise to put the health of Americans first and have called for a boycott of Roundup and other Monsanto products.
The MAHA movement, along with many environmental and health organizations, have long been advocating for stricter regulations and labeling requirements for glyphosate. They argue that the EPA’s determination is based on outdated and industry-funded studies and that there is enough evidence to suggest that glyphosate is indeed a carcinogen.
The decision to back Monsanto also goes against the growing trend of countries and cities around the world banning the use of glyphosate. In 2015, the World Health Organization’s International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans.” This has led to bans in countries such as Austria, Belgium, and Colombia, as well as cities like Miami and Los Angeles.
The Trump administration’s support for Monsanto in this legal battle is not surprising, given the close ties between the company and the administration. Former Monsanto executive, Michael D. Antonovich, was appointed as the head of the EPA’s chemical safety office in 2017, and the company’s former lobbyist, Andrew Wheeler, is now the head of the EPA.
This decision by the Trump administration has sparked outrage and disappointment among those who were hoping for a change in the government’s approach to environmental and health issues. It also raises questions about the administration’s commitment to putting the health and well-being of Americans first.
In conclusion, the Trump administration’s decision to back Monsanto in its legal battle over Roundup is a controversial move that has angered many, especially those in the MAHA movement. It remains to be seen how this will play out in the Supreme Court and what impact it will have on the ongoing debate surrounding glyphosate and its potential health risks. One thing is for sure, this decision has only added fuel to the fire of the ongoing battle between corporate interests and the health of the people.
